Revolade (Eltrombopag) is a medication used to increase platelet counts in patients with conditions that cause low platelets, helping reduce bleeding risk and improve overall stability.
What is Revolade (Eltrombopag)?
Revolade belongs to a class of drugs known as Thrombopoietin Receptor Agonists (TPO receptor agonists).
It works by stimulating the bone marrow to produce more platelets, helping to:
Increase platelet count
Reduce the risk of bleeding
Improve stability in chronic low platelet conditions
In simple terms: It helps the body produce platelets more effectively.
Indications
Revolade (Eltrombopag) is used in:
Chronic Immune Thrombocytopenia (ITP)
Certain cases of aplastic anemia
Low platelet counts associated with specific diseases or treatments
Dosage and Administration
Standard dose: 50 mg once daily
Taken orally
Must be used according to physician instructions
Dose may vary depending on lab results and patient response
Common Side Effects
May include:
Headache
Nausea
Fatigue
Elevated liver enzymes
Muscle pain
Mild digestive disturbances
Regular monitoring is important during treatment.
Monitoring During Treatment
Patients on Revolade (Eltrombopag) require:
Platelet count monitoring
Liver function tests
Complete blood count (CBC)
Evaluation of treatment response
Availability & How to Access Treatment
Revolade (Eltrombopag) is available through Macrocare’s approved partners.
You can now request and access the medication easily through us.
WhatsApp contact for medication requests: Click here
Revolade (Eltrombopag)Revolade (Eltrombopag) 50 mg is an effective treatment that helps increase platelet counts and reduce bleeding risks in patients with chronic thrombocytopenia.
Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Treatment decisions should always be made by a qualified physician.
